PCORI Funds Head-To-Head Drug Trial For Non-diabetic Neuropathy
This article was originally published in The Pink Sheet Daily
Executive Summary
Four drugs will be entered into an adaptive trial to find out which one is most effective and has the fewest side effects for treating cryptogenic sensory polyneuropathy, a designation for neuropathy for which no cause is found.
You may also be interested in...
PCORI To Solicit More Head-To-Head Comparative Studies
The Patient-Centered Outcomes Research Institute announces plans to encourage the submission of more proposals for head-to-head clinical comparative effectiveness studies. Among the research topics the institute will encourage are the Institute of Medicine’s top 100 priorities and recommendations from America’s Health Insurance Plans.
FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.
FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.